{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:38:41Z","timestamp":1793871521839,"version":"4.6.1"},"reference-count":28,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"unspecified","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chunfang Yu","award":["20210227-8-5"],"award-info":[{"award-number":["20210227-8-5"]}]},{"name":"Chunfang Yu","award":["2021KY0521"],"award-info":[{"award-number":["2021KY0521"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,1,16]]},"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To classify subgroups of cancer-related symptoms in patients with multiple myeloma (MM) during treatment and examine between-group differences in demographic and clinical characteristics in addition to functional status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional survey study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Haematology department of two tertiary hospitals affiliated with Guilin Medical University in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Using a convenience sampling method, questionnaires were distributed to patients with MM visiting two hospitals in Guilin, China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>The patients were categorised into subgroups based on cancer-related symptoms using a latent class analysis. An analysis of covariance was performed to examine how demographic and clinical characteristics and functional status differed among the subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 216 patients completed the survey, with an average age of 60.3 years. A three-class solution was identified: low symptom burden group (class 1, 36.6%), moderate symptom burden group (class 2, 34.2%) and high symptom burden group (class 3, 29.2%). Patients with low monthly family income (OR=3.14, p=0.010) and complications of MM bone disease (OR=2.95, p=0.029) were more likely to belong to class 2. The predictors of high-burden symptoms were treated with painkillers, antidepressants or hypnotic drugs (OR=3.68, p=0.012) and &lt;5000 daily step counts (OR=2.52, p=0.039) in class 3. Functional status was correlated with symptom burden, with patients in classes 3 and 1 reporting significantly higher and lower functional status, respectively (p&lt;0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with MM experienced varying degrees of symptoms during treatment. The identification of patients with high symptom burden management should focus on the assessment of demographic and clinical characteristics, in addition to functional status.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-066467","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T10:26:18Z","timestamp":1678789578000},"page":"e066467","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Classification of symptom subtypes in patients with multiple myeloma during treatment: a cross-sectional survey study in China"],"prefix":"10.1136","volume":"13","author":[{"given":"Chunfang","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Hematopathology, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Cai","sequence":"additional","affiliation":[{"name":"Fudan University School of Nursing, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhou","sequence":"additional","affiliation":[{"name":"Fudan University School of Nursing, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liang","sequence":"additional","affiliation":[{"name":"Guangxi Normal University, Guilin, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Department of Nursing, Peking Union Medical College Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8480-2569","authenticated-orcid":false,"given":"Changrong","family":"Yuan","sequence":"additional","affiliation":[{"name":"Fudan University School of Nursing, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"2025121409400442000_13.3.e066467.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-609461"},{"key":"2025121409400442000_13.3.e066467.2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/1049909116646337","article-title":"Self-reported quality of life and symptom burden in ambulatory patients with multiple myeloma on disease-modifying treatment","volume":"34","author":"Kiely","year":"2017","journal-title":"Am J Hosp Palliat Care"},{"key":"2025121409400442000_13.3.e066467.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2410-2","article-title":"The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study","volume":"16","author":"Ramsenthaler","year":"2016","journal-title":"BMC Cancer"},{"key":"2025121409400442000_13.3.e066467.4","first-page":"467","article-title":"Symptom burden and its functional impact in patients with \u201csymptomatic\u201d relapsed or refractory multiple myeloma","volume":"29","author":"Kamal","year":"2021","journal-title":"Support Care Cancer"},{"key":"2025121409400442000_13.3.e066467.5","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/cncr.30546","article-title":"Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation","volume":"123","author":"El-Jawahri","year":"2017","journal-title":"Cancer"},{"key":"2025121409400442000_13.3.e066467.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2011.08.011"},{"key":"2025121409400442000_13.3.e066467.7","first-page":"2075","article-title":"Patient-reported outcomes in relapsed\/refractory multiple myeloma: a systematic review","volume":"26","author":"Sparano","year":"2018","journal-title":"Support Care Cancer"},{"key":"2025121409400442000_13.3.e066467.8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2017.11.015","article-title":"A latent class analysis of PTSD symptoms among inner city primary care patients","volume":"98","author":"Rahman","year":"2018","journal-title":"J Psychiatr Res"},{"key":"2025121409400442000_13.3.e066467.9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11136-021-02906-1","article-title":"Psychometric properties of the PROMIS-57 questionnaire, Norwegian version","volume":"31","author":"Rimehaug","year":"2022","journal-title":"Qual Life Res"},{"key":"2025121409400442000_13.3.e066467.10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s11136-018-2058-2","article-title":"Validation of the patient-reported outcomes measurement information system (PROMIS) -57 and -29 item short forms among kidney transplant recipients","volume":"28","author":"Tang","year":"2019","journal-title":"Qual Life Res"},{"key":"2025121409400442000_13.3.e066467.11","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/acaa128"},{"key":"2025121409400442000_13.3.e066467.12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10705510701575396","article-title":"Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study","volume":"14","author":"Nylund","year":"2007","journal-title":"Structural Equation Modeling: A Multidisciplinary Journal"},{"key":"2025121409400442000_13.3.e066467.13","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1111\/jan.13991","article-title":"Subtypes of overtime work and nurses\u2019 fatigue, mental status, and work engagement: a latent class analysis of Japanese Hospital nurses","volume":"75","author":"Watanabe","year":"2019","journal-title":"J Adv Nurs"},{"key":"2025121409400442000_13.3.e066467.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2012.11.003"},{"key":"2025121409400442000_13.3.e066467.15","first-page":"417","article-title":"Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study","volume":"22","author":"Jordan","year":"2014","journal-title":"Support Care Cancer"},{"key":"2025121409400442000_13.3.e066467.16","first-page":"833","article-title":"Symptom experience of multiple myeloma (symmex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study","volume":"26","author":"Naegele","year":"2018","journal-title":"Support Care Cancer"},{"key":"2025121409400442000_13.3.e066467.17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/ejh.12790","article-title":"Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis","volume":"97","author":"Ramsenthaler","year":"2016","journal-title":"Eur J Haematol"},{"key":"2025121409400442000_13.3.e066467.18","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.1016\/j.clml.2021.05.002","article-title":"Trajectory of symptoms in patients undergoing autologous stem cell transplant for multiple myeloma: a population-based cohort study of patient-reported outcomes","volume":"21","author":"Ebraheem","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2025121409400442000_13.3.e066467.19","first-page":"4097","article-title":"Depressive symptoms, mental health-related quality of life, and survival among older patients with multiple myeloma","volume":"28","author":"Alobaidi","year":"2020","journal-title":"Support Care Cancer"},{"key":"2025121409400442000_13.3.e066467.20","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.7305"},{"key":"2025121409400442000_13.3.e066467.21","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1016\/j.clml.2020.11.021","article-title":"Prevalence and survival impact of self-reported symptom and psychological distress among patients with multiple myeloma","volume":"21","author":"Richter","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2025121409400442000_13.3.e066467.22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ctrv.2016.11.004","article-title":"Depression in cancer: the many biobehavioral pathways driving tumor progression","volume":"52","author":"Bortolato","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"2025121409400442000_13.3.e066467.23","first-page":"6099","article-title":"Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial","volume":"29","author":"Wang","year":"2021","journal-title":"Support Care Cancer"},{"key":"2025121409400442000_13.3.e066467.24","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3389\/fonc.2019.01513","article-title":"Prevalence and incidence of multiple myeloma in urban area in China: a national population-based analysis","volume":"9","author":"Wang","year":"2019","journal-title":"Front Oncol"},{"key":"2025121409400442000_13.3.e066467.25","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3196"},{"key":"2025121409400442000_13.3.e066467.26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.0827"},{"key":"2025121409400442000_13.3.e066467.27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12282-020-01168-y","article-title":"Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms","volume":"28","author":"Hsu","year":"2021","journal-title":"Breast Cancer"},{"key":"2025121409400442000_13.3.e066467.28","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2011.03.014"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-066467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:40:16Z","timestamp":1765734016000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-066467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,14]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1136\/bmjopen-2022-066467"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-066467","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}